Bogomolets National Medical University
OrganisationROR
Trials
Phase 3, Status unknown, 60 people, 7 Jul 2017
Phase 4, Completed, 70 people, 14 Jul 2015
Grants and prizes
HORIZON-RIA, SGLT2 INHIBITION FOR CARDIOVASCULAR ENDPOINT REDUCTION IN HYPERTENSION (SGLT2-HYPE), 101156555, €58.2k, 2025–2032, 10 Dec 2024
Sources: cordis.europa.eu